Last reviewed · How we verify
MDPK67b
At a glance
| Generic name | MDPK67b |
|---|---|
| Sponsor | Med Discovery SA |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- MDPK67b in Patients With Prostate Cancer (PHASE1)
- PK, PD, Tolerability and Safety of MDPK67b in Healthy Volunteers (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- MDPK67b CI brief — competitive landscape report
- MDPK67b updates RSS · CI watch RSS
- Med Discovery SA portfolio CI